APA (7th ed.) Citation

Leng, W., Ouyang, X., Lei, X., Wu, M., Chen, L., Wu, Q., . . . Liang, Z. The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/− Mice. Wiley.

Chicago Style (17th ed.) Citation

Leng, Weiling, Xinshou Ouyang, Xiaotian Lei, Mingxia Wu, Liu Chen, Qinan Wu, Wuquan Deng, and Ziwen Liang. The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/− Mice. Wiley.

MLA (9th ed.) Citation

Leng, Weiling, et al. The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/− Mice. Wiley.